Aaron Boster

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Multiple Sclerosis

Ejection Fraction

Top Venues

Multiple sclerosis journal - experimental, translational and clinical

Multiple sclerosis (Houndmills, Basingstoke, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Alasdair J Coles, Joanne L Jones, Patrick Vermersch, Anthony Traboulsee, Ann D Bass, Aaron Boster, Andrew Chan, Giancarlo Comi, Óscar Fernández, Gavin Giovannoni, Eva Kubala Havrdova, Christopher LaGanke, Xavier Montalban, Celia Oreja-Guevara, Fredrik Piehl, Heinz Wiendl, Heinz Wiendl
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data. Multiple sclerosis (Houndmills, Basingstoke, England) (2021)
Dana Horáková, Aaron Boster, Antonio Bertolotto, Mark S Freedman, Isabel Firmino, Steven J Cavalier, Alan K Jacobs, Karthinathan Thangavelu, Nadia Daizadeh, Elizabeth M Poole, Darren P Baker, David H Margolin, Tjalf Ziemssen, null null
Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years. Multiple sclerosis journal - experimental, translational and clinical 6 (4) (2020)